Sort
4,870 grants matching “glp 1”
Co-registration of Cell Organization, Phenotype and Function in the Human Pancreas During Type 1 Diabetes
$506,783Mark A Atkinson · University Of Florida · R01 · FY2025 · DK
Fluxomics Studies of the Effect of Diet Composition on Energy Metabolism
$506,598Sheng Hui · Harvard University D/B/A Harvard School Of Public Health · R56 · FY2024 · DK
Optical sensor-enabled endotracheal tube to reduce esophageal intubation and unintended extubation
$506,500Felek Jachimowicz · Endolynx Inc · R43 · FY2024 · HL
Identification of drugs that delay aging
$506,187Kerry Kornfeld · Washington University · R56 · FY2018 · AG
Bone metabolism in adolescents undergoing GLP-1 receptor agonist therapy
$505,734Madhusmita Misra · University Of Virginia · R01 · FY2025 · HD
Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning
$505,514Steven E Patterson · University Of Minnesota · U01 · FY2020 · NS
Individual and Group Career Development Program
$505,504Jennifer Snyder · University Of Maryland Baltimore · U54 · FY2011 · AI
The Chesapeake-Ohio Pharmacokinetics Core for The ETCTN
$505,279Michael A. Carducci · Johns Hopkins University · U24 · FY2023 · CA
Pediatric Pharmacology Research Unit Network
$505,278Jeffrey Scott Barrett · Children'S Hosp Of Philadelphia · U10 · FY2007 · HD
Late Stage Development of Sustained-release Relaxin for Treating Joint Contracture
$504,965Benjamin Goldman Cooper · Ortholevo, Inc. · SB1 · FY2024 · AR
Late Stage Development of Sustained-release Relaxin for Treating Joint Contracture
$504,601Benjamin Goldman Cooper · Ortholevo, Inc. · SB1 · FY2025 · AR
GLP-1 to Enhance Islet Transplantation
$504,205Alvin Carter Powers · Vanderbilt University · R33 · FY2007 · DK
Fatty Acid Signaling via GPCRs in Primary Cilia Controls Adipogenesis and Insulin Secretion, Regulating Obesity and Diabetes
$504,136Peter Kent Jackson · Stanford University · R01 · FY2023 · DK
Fatty Acid Signaling via GPCRs in Primary Cilia Controls Adipogenesis and Insulin Secretion, Regulating Obesity and Diabetes
$504,059Peter Kent Jackson · Stanford University · R01 · FY2022 · DK
GLP-1 to Enhance Islet Transplantation
$503,260Alvin Carter Powers · Vanderbilt University · R33 · FY2006 · DK
Lipid transport in the intestine
$503,237Judith Storch · Rutgers, The State Univ Of N.J. · R01 · FY2022 · DK
Resource Core II: In Vivo Core
$503,215Victor Steven Van Laar · University Of California Berkeley · U19 · FY2024 · NS
Integration of Genomic Biomarkers with the devTOX Human Embryonic Stem Cells Scre
$502,613Leslie Recio · Integrated Laboratory Systems, Llc · R44 · FY2015 · ES
Third generation liver-directed dual-function AAT vectors
$502,500Christian Mueller · Univ Of Massachusetts Med Sch Worcester · P01 · FY2020 · HL
Third generation liver-directed dual-function AAT vectors
$502,500Christian Mueller · Univ Of Massachusetts Med Sch Worcester · P01 · FY2016 · HL
Third generation liver-directed dual-function AAT vectors
$502,500Christian Mueller · Univ Of Massachusetts Med Sch Worcester · P01 · FY2019 · HL
Core--Formulation Science
$502,324Russell J Mumper · Starpharma, Ltd · U19 · FY2007 · AI
Evaluating Mechanisms and Therapeutic Potential of (GLP-1R) Agonists for Glaucoma Treatment
$501,664Qi Nannan Cui · University Of Pennsylvania · R01 · FY2025 · EY
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
$501,311Mary L. Michaelis · University Of Kansas Lawrence · U01 · FY2011 · AG
Early Prediction of Tumor Response to Treatment: Clinical Translation of [99mTc]-Duramycin
$500,963Koon Y Pak · Molecular Targeting Technologies, Inc. · R01 · FY2022 · CA